Regional News
Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer
HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medic...
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan
- Secures distribution agreement to launch CART BP pro in the Japanese hospital and clinic market - Leveraging proven technology with adoptions in 1,700+ medical institutions and national health insurance coverage in Korea SEOUL, South Korea, Feb. 5, 2026 /PRNewswire/ -- Sky Labs Inc. (CEO Jack ...
VARON Marks Valentine's Day With Health-Focused Savings That Put Care First
Love looks like care. This Valentine's Day, VARON invites families to show love
in a way that helps loved ones breathe easier—at home and on the go.
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- VARON
Monport Positions Laser Engraving as a Growing Trend for Valentine's Day Personalized Gifts
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- As Valentine's Day approaches, Monport
Laser
Dreame Launches Aero Pro: The Next-Generation Wet Dry Vacuum with Ultra-Thin Design for Effortless, Deeper Cleaning
LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Dreame, a global innovator in smart home, today announced the launch of the Aero Pro, a wet dry vacuum engineered to be the slim, strong, next-generation cleaner. It delivers a unique combination of power, access, and intelligence—with a groundbreaking ul...
COSRX's Viral Peptide Eye Patch Gets a Pink Makeover for Limited Valentine's Skincare Drop Now on Amazon
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Just in time for Valentine's day,
science-driven K-beauty brand COSRX is launching a limited-edition Pink version
of its viral bestseller,The Peptide Collagen Hydrogel Eye Patch
LifeZoom Introduces the Oclux Red Light Eye Mask--A Naturally Restorative, Aesthetics-Driven Solution for the Effects of Screen-Based Life
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- LifeZoom, a natural-restorative brand, today launches Oclux, a red light eye mask that expands the company's red light product lineup. Positioned as a holistic solution that balances visual aesthetics, user experience, and daily rhythms, Oclux is designed to...
2026 Spring Festival Gala Cultural Pop-up Stores Debut in Yiwu: When Artistry Meets Urban Vibrancy
YIWU, China, Feb. 5, 2026 /PRNewswire/ -- A news report from Yiwu Media Convergence Center:   On February 4th, the 2026 Spring Festival Gala Cultural Pop-up Store at the Yiwu Centre shopping district was bustling with crowds. Inside, a dazzling array of creative products fi...
e-STORAGE and Sunraycer Announce 503 MWh Battery Energy Storage Projects in Texas
KITCHENER, ON, Feb. 5, 2026 /PRNewswire/ -- Canadian Solar Inc.
Jin Medical CEO Fireside Chat
CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat onFebruary 2, 2026 where the CEO sha...
NITECORE Sets a New Standard for Ultralight Power: the New 143g, IPX7-Rated NB10000 Gen4
GUANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- The NITECORE
DLG Launches LuxuryIQ MCP: The Luxury Industry's First AI Data Integration Layer
GENEVA, Feb. 5, 2026 /PRNewswire/ -- DLG (Digital Luxury Group)
Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion
GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show, t...
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
* NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source. * Unlike ISM8969, Insilico's brain-penetrant NLR...
Iron Software Sees 200% Increase in Agentic AI Adoption for HTML to PDF C# Workflows with IronPDF
A decade of building reliable document processing tools—including the
industry-leading IronPDF library forHTML to PDF C# conversion
Global Times: China's No.1 central document in starting year of 15th Five-Year Plan sets agricultural modernization roadmap, turning rural potential into growth momentum
BEIJING, Feb. 5, 2026 /PRNewswire/ -- China unveiled its "No.1 central document" for 2026 on Tuesday, outlining plans to advance agricultural and rural modernization and to promote all-around rural revitalization, according to the Xinhua News Agency. As the first major policy document on agricul...
A Subsidiary of AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C to Serve as an Event Coordinator for 2026 Middle East Consumer Electronics Show
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C ("Ambitions" or "the Company") (NASDAQ: AHMA), a UAE-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced that its wholly-owned subsidiary, MULTIPLE EVENTS ...
Cloopen Announces Changes to Board of Directors and Committee Membership
BEIJING, Feb. 5, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has approved resolutions regarding changes to the composition of the Board and the Compensation Committee, effectiveFebruary 5, 2...
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
TOKYO and SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters:Shanghai, China, CEO: Jason Zhu, "Henlius") announced today the conclusion of an exclusive commercialization and co-exclusive developm...
HanchorBio Accelerates Global Clinical Footprint with Multiple Oral and Poster Presentations in Q1 2026
Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO-GI, AACR-IO, ESMO-TAT, ICNHO, and WOC TAIPEI and SHANGHAI and SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechno...
Week's Top Stories
Most Reposted
Wonder Raises USD 12 Million Venture Debt from HSBC Innovation Banking to Drive Growth and Expansion
[Picked up by 323 media titles]
2026-02-02 10:00AI adoption is widespread, but developer confidence is still catching up, Agoda report finds
[Picked up by 314 media titles]
2026-02-03 11:00Mastercard Launches Portfolio of Fleet Solutions in Asia Pacific
[Picked up by 311 media titles]
2026-02-04 09:00Colebrook Bosson Saunders Officially Launches Lana, A Circular Ergonomic Laptop Stand for the Hybrid Generation
[Picked up by 305 media titles]
2026-02-03 12:00Singapore Airshow 2026 Milestone Edition: 20 Years of Shaping the Aerospace Landscape as Asia-Pacific Drives Global Growth
[Picked up by 288 media titles]
2026-02-01 19:35